Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Lang Lin

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
World Journal of Surgical Oncology|January 28, 2012
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case reportChin-Ying Chien, Cheng-Cheng Hwang, Chun-Nan Yeh, et al.
Scientific Reports|April 2, 2017
A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic PatientsYa-Hui Huang, Kung-Hao Liang, Rong-Nan Chien, et al.
Medicine|May 6, 2016
The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based StudyLi-Wei Chen, Chih-Yi Chien, Chia-Wen Hsieh, et al.
Scientific Reports|August 31, 2017
Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based StudyCheng-Hung Chien, Li-Wei Chen, Chih-Lang Lin, et al.
Cancers|July 14, 2023
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral TherapyChih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, et al.
Journal of Hepatology|March 4, 2014
Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensationChien-Hung Chen, Chih-Lang Lin, Tsung-Hui Hu, et al.
Journal of Medical Virology|August 31, 2019
Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019Kuan-Chieh Lee, Chih-Lang Lin, Chao-Wei Hsu, et al.
Scientific Reports|May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysisChun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
BMC Gastroenterology|April 18, 2021
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patientsKung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, et al.
Journal of Gastroenterology and Hepatology|February 10, 2018
Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluationChristopher Sung-Huan Yeh, Chao-Wei Hsu, Kung-Hao Liang, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
World Journal of Surgical Oncology|January 28, 2012
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case reportChin-Ying Chien, Cheng-Cheng Hwang, Chun-Nan Yeh, et al.
Scientific Reports|April 2, 2017
A Circulating MicroRNA Signature Capable of Assessing the Risk of Hepatocellular Carcinoma in Cirrhotic PatientsYa-Hui Huang, Kung-Hao Liang, Rong-Nan Chien, et al.
Medicine|May 6, 2016
The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based StudyLi-Wei Chen, Chih-Yi Chien, Chia-Wen Hsieh, et al.
Scientific Reports|August 31, 2017
Unawareness of Hepatitis B Virus Infection confers on Higher Rate of Metabolic Syndrome: A Community-based StudyCheng-Hung Chien, Li-Wei Chen, Chih-Lang Lin, et al.
Cancers|July 14, 2023
Predicting Hepatocellular Carcinoma Risk in Chronic Hepatitis B Patients Receiving Finite Periods of Antiviral TherapyChih-Lang Lin, Szu-Yuan Wu, Ming-Wei Lai, et al.
Journal of Hepatology|March 4, 2014
Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensationChien-Hung Chen, Chih-Lang Lin, Tsung-Hui Hu, et al.
Journal of Medical Virology|August 31, 2019
Decreasing seroprevalence of anti-hepatitis D virus antibodies in the antiviral era with inverse association with hepatitis B virus DNA, Taiwan, 2006 to 2019Kuan-Chieh Lee, Chih-Lang Lin, Chao-Wei Hsu, et al.
Scientific Reports|May 10, 2019
Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysisChun-Hsien Chen, Chien-Hung Chen, Chih-Lang Lin, et al.
BMC Gastroenterology|April 18, 2021
Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patientsKung-Hao Liang, Ming-Wei Lai, Yang-Hsiang Lin, et al.
Journal of Gastroenterology and Hepatology|February 10, 2018
Development of a fibrosis index including hepatitis B virus basal core promoter A1762T mutation for pretherapeutic evaluationChristopher Sung-Huan Yeh, Chao-Wei Hsu, Kung-Hao Liang, et al.
Pageof 11